Journal: Frontiers in Public Health
Article Title: Serum Angiopoietin-Like Protein 4: A Potential Prognostic Biomarker for Prediction of Vascular Invasion and Lymph Node Metastasis in Cholangiocarcinoma Patients
doi: 10.3389/fpubh.2022.836985
Figure Lengend Snippet: (A) Serum ANGPTL4 level of HC and CCA patients by dot blot assay. The median ± quartile deviation, 0.1634 ± 0.1739 AU (0.0193–0.9424 AU), in healthy control and 0.6017 ± 0.3767 AU (0.0984–2.9526 AU) in CCA patients' group. To normalize the expression level, the ratio of the intensity of each dot blot to that of the positive control (pooled CCA serum) was calculated and determined as the arbitrary unit (AU). The difference of serum ANGPTL4 level between HC and CCA by Mann-Whitney U-test. (B) ROC curve of serum ANGPTL4 level as a potential biomarker for prediction of CCA in comparison group of HC, sensitivity = 80.0% and specificity = 72.7% (AUC = 0.825, 95% CI 0.751–0.899, p < 0.0001). Statistical significance ( p < 0.05).
Article Snippet: To correlate serum ANGPTL4 level between dot blot assay and ELISA, we determined ANGPTL4 level in randomly selected 20 samples using ANGPTL4 commercially quantitative sandwich ELISA kit (DY3485, R and D systems, USA) according to manufacturer's instructions.
Techniques: Dot Blot, Control, Expressing, Positive Control, MANN-WHITNEY, Biomarker Discovery, Comparison